Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

The objective of this study was to assess the cost-effectiveness (CE) and budget impact of liraglutide vs standard-of-care (SoC) in T2D patients with established cardiovascular disease (CVD) or elevated cardiovascular (CV) risk, over a lifetime horizon f https://www.dovepress.com/cost-effectiveness-and-budget-impact-of-liraglutide-in-type-2-diabetes-peer-reviewed-article-CEOR